CID 169501959

Bilastine metabolite-glucuronide

Structural Information

Molecular Formula
C22H31N3O7
SMILES
CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)C4C(C(C(C(O4)C(=O)O)O)O)O
InChI
InChI=1S/C22H31N3O7/c1-2-31-12-11-25-15-6-4-3-5-14(15)23-20(25)13-7-9-24(10-8-13)21-18(28)16(26)17(27)19(32-21)22(29)30/h3-6,13,16-19,21,26-28H,2,7-12H2,1H3,(H,29,30)
InChIKey
KUMKWWIRJWVNFQ-UHFFFAOYSA-N
Compound name
6-[4-[1-(2-ethoxyethyl)benzimidazol-2-yl]piperidin-1-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

449.2162 Da
Monoisotopic Mass

-2.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 450.223476 206.8
[M+Na]+ 472.205418 210.3
[M-H]- 448.208924 208.6
[M+NH4]+ 467.250023 210.0
[M+K]+ 488.179358 207.0
[M+H-H2O]+ 432.213460 197.1
[M+HCOO]- 494.214401 212.2
[M+CH3COO]- 508.230051 225.5
[M+Na-2H]- 470.190866 201.9
[M]+ 449.21565142 205.0
[M]- 449.21674858 205.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.